Scientific Update

Scientific Update are returning to Chemspec India 2012 to host a series of technical workshops in a purpose built theatre directly on the show floor.
Scientific Update, established in 1989 by Dr. Trevor Laird, organises conferences and training courses for industrial chemists, chemical engineers in chemical development and scale-up and many other specialist topics in organic chemistry.
This year's topics will include:
Novel Technologies; possible directions of development and scale-up / Is batch processing yesterday's technology?
• Discusses the possibility of using more continuous processing in pharmaceutical production
• Discusses the impact of microreactors by example
• The intention is to stimulate the audience and provoke some discussion.
Although batch processes have been operated for many decades and have the advantage of being able to be used in multipurpose reactors, they are not the most efficient and may not always give the best yield and selectivity, which translates into cost of manufacture.
New technologies for continuous processing, which retain the advantages of batch process equipment (suitable for small scale manufacture, flexibility etc) may offer advantages of ease of scale up and selectivity in the chemical reaction as well as efficiency in throughput.
This provocative presentation and discussion aim to highlight developments in process intensification, and its perceived benefits, and to stimulate discussion regarding the technology likely to be applied in the future chemical processing plant in the fine chemical, pharmaceutical and allied fields.
East vs West - contrasting styles of development
A discussion centred around different drivers for chemical development in Asian CROs/CMOs in comparison with those typically seen in Western CROs/CMOs. The presentation will use case studies from early development projects and offer views and on mutual learning opportunities and future directions.
Drug Candidate Synthesis
• Surveys the range and frequency of reaction types used to prepare drug candidates
• Discusses how chirality and key heterocyclic synthons are most often accessed
• Examines some of the constraints faced by pharmaceutical development chemists
• Highlights current gaps in the process chemist's synthetic armoury




